Akèy › Oftalmopati Graves
Etid klinik pou Oftalmopati Graves ap rekrite nan Etazini
6 etid pou Oftalmopati Graves ap rekrite patisipan nan sit atravè Etazini.
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
A Study of VV-14305 for the Treatment of Thyroid Eye Disease
Ap rekriteFaz 1/2
Laj 18 a 80 · Tout sèks · Mizajou Aug 27, 2026 · NCT07404111Study to Assess Linsitinib in Participants With Moderate to Severe Active Thyroid Eye Disease (TED)
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Aug 11, 2026 · NCT07753603An Open-label, Rollover Trial to Evaluate the Efficacy and Safety of AMG 732 in Participants With Thyroid Eye Disease
Ap rekriteFaz 2
Laj 18 a 99 · Tout sèks · Mizajou Jul 23, 2026 · NCT07438405Bimatoprost as a Treatment for Graves' Orbitopathy
Ap rekriteFaz 1 bonè
Laj 18 ak plis · Tout sèks · Mizajou Jul 16, 2026 · NCT03708627Extension Study of Two Doses of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED)
Ap rekriteFaz 2/3
Laj 18 ak plis · Tout sèks · Mizajou Feb 25, 2025 · NCT06112340The Effect of Teprotumumab on Thyroid Eye Disease and Thyroid Dysfunction
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Feb 23, 2024 · NCT06275373Sous ClinicalTrials.gov, done yo ranmase Oct 2, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.